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Abstract  
Background: Ankylosing spondylitis, is a chronic inflammatory autoimmune disease 
that mainly affects spine joints. It can cause severe, chronic pain, spine fusion and 
chronic disability. Ehlers-Danlos syndrome is a rare heterogenous group of hereditary 
connective tissue disorders which are characterized by skin hyperextensibility, joint 
hypermobility and tissue fragility. 
Case report: A 33-year old man was admitted to the Rheumatology Department of 
251 Airforce General Hospital in order to decide on his capability to serve his duty as 
an aircraftsman at Hellenic Airforce. He was diagnosed with ankylosing spondylitis 
twelve years ago. On physical examination joint hypermobility and skin 
hyperextensibility were observed and after further investigation, he was diagnosed 
with hypermobility type of Ehlers Danlos Syndrome. Laboratory investigation was 
normal. MRI radiologic investigation revealed bony sclerosis of the left sacroiliac 
joint and bone marrow oedema on right sacroiliac joint. No extraskeletal 
manifestations were detected. The patient was informed about both conditions and he 
was given medical advice about their proper management.   
Conclusion: Rare diseases sometimes manifest as atypical inflammatory arthritis 
syndromes. Careful medical history, thorough physical examination and use of 
diagnostic criteria are useful in such patients for disease identification and treatment.  
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Abbreviations 
SpA: Spondyloarthrtitis  
AS: ankylosing spondylitis 
PsA: psoriatic arthritis 
ReA: reactive arthritis 
NSAIDs: non-steroidal anti-inflammatory drugs 
bDMARDs: biological disease-modifying antirheumatic drugs 
EDS: Ehlers-Danlos syndrome 
cEDS: classic EDS 
cvEDS: cardiac – valvular EDS 
hEDS: hypermobile EDS 
vEDS: vascular EDS 
kEDS: kyphoscoliotic EDS  
aEDS: arthrochalasia EDS 
dEDS: dermatosparaxis EDS 
BCS: brittle cornea syndrome  
spEDS: spondylodysplastic EDs 
mcEDS: musculocontractural EDS 
mEDS: myopathic EDS  
pEDS: periodontal EDS  
JHS: joint hypermobility syndrome  
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Introduction  
Spondyloarthrtitis (SpA) is a 
heterogenous group of chronic 
inflammatory arthropathies. They 
affect not only the spine but also 
certain extra articular sites (Zhu et al, 
2019) . The SpA group includes axial 
SpA - including ankylosing spondylitis 
(AS), peripheral SpA, psoriatic 
arthritis (PsA), enteropathic arthritis, 
reactive arthritis (ReA) and juvenile 
SpA (Carli et al, 2019). AS usually 
begins in late adolescence or early 
adulthood. Onset after the age of 45 is 
uncommon. It affects mostly males 
(F:Μ ratio 2-3:1). The typical AS 
patient presents with low back pain 
with prolonged morning and 
sometimes nocturnal stiffness which 
improves only with exercise. Another 
feature of AS is persistent buttock pain 
which may alternate from side to side 
at the early stages of the disease 
(Watad et al, 2018). Physical 
examination reveals decreased spinal 
mobility, sacroiliac joint tenderness, 
and sometimes enthesitis and reduced 
chest expansion. Radiographic 
sacroilitis is the hallmark of AS and 
there is a strong association with HLA- 
B27. Exercise and NSAIDs can control 
the inflammatory symptoms. Patients 
with high disease activity and extra 
articular manifestations may benefit 
from bDMARDs such as anti-TNF and 
anti- IL17 agents (Taurog et al, 2016).  
Ehlers-Danlos syndrome (EDS) is a 
rare heterogenous group of hereditary 
connective tissue disorders which are 
characterized by skin 
hyperextensibility, joint hypermobility 
and tissue fragility. Diagnosis is based 
upon a series of major and minor 
criteria according to EDS type and 
family history. There are thirteen types 
of EDS (Jesudas et al, 2019): 
1. Classic (cEDS) 
2. Classical-like EDS 
3. Cardiac-Valvular (cvEDS) 
4. Hypermobile (hEDS) 
5. Vascular (vEDS) 
6. Kyphoscoliotic (kEDS) 
7. Arthrochalasia (aEDS) 
8. Dermatosparaxis (dEDS) 
9. Brittle cornea syndrome (BCS) 
10. Spondylodysplastic (spEDS) 
11. Musculocontractural (mcEDS) 
12. Myopathic (mEDS) 
13. Periodontal (pEDS) 
Hypermobility EDS (Tinkle et al, 
2019) includes large and small joint as 
well as spine hypermobility, frequent 
joint dislocations, scoliosis and 
premature osteoarthritis. Skin’s 
hyperextensibility is not as severe as in 
classic EDS. Wound healing is normal 
and mitral valve prolapse is 
uncommon. It is characterized by 
genetic heterogeneity. In most patients 
inheritance appears to be autosomal 
dominant but there is a rare subtype of 
this EDS type due to tenascin X 
deficiency. As a result, genetic testing 
for most patients is not available.  
Differential diagnosis includes other 
types of EDS and other connective 
tissue disorders, including Marfan 
syndrome.  
 
Case report 
A 33-year old man was admitted to the 
Rheumatology Department of 251 
Airforce General Hospital in order to 
decide on his capability to serve his 
duty as an aircraftsman at Hellenic 
Airforce. His medical history was 
remarkable for inflammatory back pain 
with prolonged morning stiffness and 
radiographic sacroiliitis starting 12 
years ago. He was also positive for 
HLA-B27. As a result, AS was 
diagnosed. He had not received any 
medication after he had been 
diagnosed with AS, except for low 
doses of aceclofenac on demand.  
The patient was clinically reexamined 
and had a complete laboratory and 
radiologic examination to confirm the 
diagnosis of AS, define the disease 
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activity and detect any extraskeletal 
manifestations of AS.  
The clinical examination revealed 
limited loss of cervical range of 
motion, normal chest expansion, 
Scober test +4cm, unilateral sacroiliac 
joint pain at Gaenslen’s test and 
Achilles enthesitis. No peripheral joint 
involvement was detected.  
Laboratory investigation was normal. 
Radiologic investigation revealed bony 
sclerosis of the left sacroiliac joint in 
plain radiographies and bone marrow 
oedema of the right sacroiliac joint in 
the MRI (Figure 1). No extraskeletal 
manifestations were detected. 
Clinical examination also revealed 
joint hypermobility (Figure 2), which 
became subject of further clinical 
investigation.   A Beighton score was 
performed (7/10). 
After the performance of an extent 
differential diagnosis (including other 
types of EDS and other connective 
tissue diseases such as Marfan 
syndrome), the most probable 
diagnoses were joint hypermobility 
syndrome (JHS) and Hypermobility 
EDS. The connection between them 
remains uncertain but the majority of 
experts considers them equal. The 
patient fulfills both Brighton criteria 
for JHS (1 major, 2 minor criteria) and 
2017 international diagnostic criteria 
for hEDS. Due to hyperextensibility 
(>5cm) of the skin the patient probably 
should be diagnosed as hypermobility 
EDS (Malfait et al, 2017). 
 
 
 
 
 
 
 
 
 
 
Figure 1: MRI of the sacroiliac joints. Bone marrow oedema of the right sacroiliac  
joint is illustrated.  
 
 
 
 
 
 
 
 
Figure 2: Passive apposition of the thumb to the flexor aspect of the forearm 
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Discussion  
The management strategy for this 
patient was divided into four steps. The 
first was to establish the diagnosis of 
AS, define the disease activity and the 
existence of extraskeletal 
manifestations such as anterior uveitis 
and IgA nephropathy. It was important 
that the diagnosis of AS was 
questioned because several 
manifestations of the disease resemble 
articular involvement of a joint 
hypermobility syndrome. There are 
clinical cases in medical literature 
which highlight that a syndrome like 
this can be misdiagnosed as arthritis 
(Rodgers et al, 2017). 
The second phase was to establish the 
diagnosis of Hypermobility EDS using 
clinical criteria. The complex 
differential diagnosis was made 
between the different types of EDS and 
other heritable connective tissue 
diseases such as Marfan syndrome. 
Careful clinical evaluation, clinical 
criteria for the diagnosis of these 
syndromes and a diagnostic flow chart 
from American Journal of Medical 
Genetics were the tools that established  
the diagnosis of Hypermobility EDS 
(Tinkle et al, 2017). 
The third and fourth steps consisted of 
providing the appropriate treatment for 
both conditions although they are 
clinically very different (Shur et al, 
2020). Regarding the low disease 
activity and the fact that the patient did 
not present extraskeletal 
manifastetions, treatment with 
NSAIDS on demand with proper 
exercise and physical therapy was 
continued. The patient was advised to 
follow an exercise and physical 
therapy program with an expert in 
order to avoid injury of hypermobile 
joints and recurrent episodes of joint 
dislocation. Finally, he was informed 
about possible medical emergencies, 
chronic pain, neurophychiatric and 
other manifestations of hypermobility 
EDS in order to look for proper 
medical care (Joseph et al, 2018). 
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